Cointime

Biofortuna

company

About

Biofortuna develops a range of molecular diagnostic products using proprietary freeze-dried technology.

  • 11 - 50

Highlights

Total Funding Amount
£3.40M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
£2.10M
Industries
Biotechnology,Health Diagnostics
Founded date
Jan 1, 2008
Number Of Employee
11 - 50
Operating Status
Active

Biofortuna provides molecular diagnostics services. It manufactures HLA and ABO genotyping product families for the transplantation and haematology markets. The company is also developing antibody screening, genotyping and phenotyping products, software for genotyping applications, transplant monitoring, and platforms for clinical laboratories, research centers and point-of-care customers. In addition, Biofortuna Ltd. provides genotyping and custom assay development services. The company was incorporated in 2008 and is based in Liverpool, the United Kingdom.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
£3.40M
Biofortuna has raised a total of £3.40M in funding over 2 rounds. Their latest funding was raised on Apr 11, 2012 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 11, 2012 Series Unknown £2.10M 1 — — Detail
Jan 1, 2012 Series Unknown £1.30M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Biofortuna is funded by 1 investors. Foresight Group are the most recent investors.
Investor Name Lead Investor Funding Round
Foresight Group — Series Unknown
Cointime
Chủ Đề
Công Ty